**In Vivo Efficacy and Safety Profile of the Pat-HBc/RSG&ZnPcS4 Nanocomplex in Obese Mouse Models**

The therapeutic potential of the Pat-HBc/RSG&ZnPcS4 nanocomplex was rigorously evaluated in obese (Ob/Ob) mice over a two-week treatment regimen involving two cycles of intravenous administration followed by abdominal laser irradiation. The study demonstrated significant anti-obesity effects, robust metabolic improvements, and an acceptable safety profile, supporting its translational viability.

Mice treated with Pat-HBc/RSG&ZnPcS4 exhibited a sustained and pronounced reduction in body weight—exceeding 10% after two cycles—compared to minimal changes in control, RSG-only, ZnPcS4-only, or combination groups without targeting. Daily monitoring revealed no significant differences in food intake across groups, confirming that weight loss was due to increased energy expenditure rather than appetite suppression. Visual inspection showed visibly leaner body contours, particularly in the abdominal region, with reduced fat pad mass confirmed at necropsy.

Photoacoustic imaging provided real-time, non-invasive assessment of treatment progression. Three-dimensional scans revealed a progressive decrease in adipose volume in iWAT, pWAT, and mWAT, with the most dramatic reduction observed in mWAT and pWAT—regions with high vascular density. Concurrently, vascular length density significantly increased, indicating active angiogenesis driven by RSG and facilitated by PDT-induced hypoxia. These findings were corroborated by histological analysis, which showed marked shrinkage of adipocytes and reduced lipid droplet size in all WAT depots, especially in pWAT and mWAT.

Metabolic health improved markedly. Fasting serum glucose and insulin levels declined, resulting in a lower insulin resistance index (IRI), suggesting enhanced insulin sensitivity. Oral glucose tolerance tests confirmed improved glucose clearance, further validating metabolic recovery. Hepatic steatosis was alleviated, as evidenced by reduced liver triglyceride content and less lipid accumulation on H&E staining, likely due to RSG’s ability to improve systemic insulin sensitivity and reduce lipotoxicity.

Histopathological evaluation of major organs—including liver, kidney, heart, lung, and spleen—revealed no signs of toxicity. Hematoxylin and eosin (H&E) staining showed normal tissue architecture with no inflammatory infiltrates, necrosis, or fibrosis. Serum biomarkers for hepatic function (ALT, AST), renal function (urea, creatinine), and cardiac function (CK, CK-MB, LDH) remained within normal ranges, indicating no organ damage. Notably, even baseline markers of oxidative stress (MDA, 4-HNE, 8-OHdG) were elevated in the Pat-HBc/RSG&ZnPcS4 group post-treatment, but this was not accompanied by clinical toxicity—suggesting controlled, localized oxidative stress confined to adipose tissue.

Immunogenicity was assessed in a separate cohort of mice sensitized with ovalbumin, HBc, or Pat-HBc. While wild-type HBc elicited strong IgG and Th2 responses (elevated IL-4), Pat-HBc induced significantly lower immunoglobulin levels and cytokine production, indicating that the insertion of the Pat peptide into the MIR region effectively masked immunogenic epitopes.MUC5AC Antibody In stock However, repeated dosing still triggered a measurable immune response, highlighting a need for future modifications such as PEGylation or use of protein orthologues to further reduce immunogenicity.Csk Antibody manufacturer

In conclusion, the Pat-HBc/RSG&ZnPcS4 complex demonstrates potent, targeted anti-obesity efficacy with favorable safety and tolerability in vivo.PMID:35217923 Its ability to induce durable fat loss, enhance metabolic function, and maintain organ integrity—while minimizing systemic toxicity—positions it as a promising candidate for clinical development. The integration of photoacoustic imaging for treatment guidance further enhances precision, enabling personalized therapy. Future work will focus on optimizing biocompatibility and long-term safety to advance this strategy toward human application.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com

The quest for high-performance optoelectronic materials has traditionally centered on chemical substitution within established perovskite frameworks. However, this study demonstrates that redefining the spatial arrangement of functional [BX₆] octahedral units can lead to unprecedented electronic properties and device performance. By leveraging density functional theory (DFT) and global structure search methods based on CsPbI₃, we identified a metastable three-dimensional honeycomb-like perovskite phase where [PbI₆] octahedra are connected through a mixed edge- and corner-sharing network. This structural motif preserves high electronic dimensionality while introducing unique topological features absent in conventional perovskites. Experimental synthesis confirmed the stabilization of this fragile framework using divalent 2,2-bisimidazole (BIM) cations, which occupy flattened hexagonal cavities between paired edge-sharing octahedra. Single-crystal X-ray diffraction revealed a monoclinic C2/m structure with minimal lattice distortion, indicating that the organic component does not disrupt the extended inorganic network. The resulting BIMPb₂I₆ material exhibits a direct allowed bandgap of 2.GIRK2 Antibody In Vivo 1 eV, as confirmed by UV–Vis absorption and Tauc plot analysis, with excitonic binding energy estimated at ~40 meV.HLA-DRA Antibody References DFT calculations show that both valence and conduction bands are derived from Pb–I hybrid orbitals, with negligible contribution from the BIM cation due to its high electropositivity and lack of localized molecular states near the band edges.PMID:34784422 This ensures that charge transport remains dominated by the 3D inorganic framework. Electron and hole effective masses are calculated as 0.22m₀ and 0.24m₀, respectively, indicating strong carrier delocalization. Optical absorption coefficients exceed 10⁵ cm⁻¹, enabling efficient light harvesting. Photoluminescence measurements reveal a sharp emission peak at 627 nm, confirming radiative recombination of free excitons, while a secondary shoulder suggests shallow trap states. A photodetector fabricated from a BIMPb₂I₆ single crystal shows a responsivity of 0.1 mA/W and photodetectivity of 1.1 × 10¹⁰ Jones under 637 nm illumination. Switching cycles demonstrate stable and repeatable photoresponse with rise and fall times of 1.0 ms and 0.8 ms, respectively. These results confirm that engineered spatial connectivity of functional octahedral units can yield materials with superior optoelectronic characteristics, even when departing from conventional perovskite geometries. This work establishes a new paradigm: structural design through controlled assembly of functional units is a powerful strategy for discovering next-generation semiconductors with tailored performance.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com

A 29-year-old male healthcare worker, previously healthy and without prior exposure to heparin, received the ChAdOx1 nCoV-19 adenoviral vector vaccine on March 29. Nine days later, he developed persistent headache and abdominal pain. By day 12, symptoms progressed to vomiting and severe abdominal cramps. On day 14, he was admitted urgently due to worsening headache and hematemesis. Laboratory findings revealed profound thrombocytopenia at 32/nL. Gastroscopy demonstrated diffuse gastric mucosal bleeding, indicating significant gastrointestinal hemorrhage. Brain MRI showed complete occlusion of the left transverse and sigmoid sinuses extending into the proximal left jugular vein—diagnostic of cerebral sinus venous thrombosis (Fig. 1a). Abdominal CT angiography confirmed extensive thrombosis involving the portal and mesenteric veins, explaining the source of ongoing bleeding.

Given the temporal association with vaccination, absence of heparin exposure, and presence of multi-system thrombosis with thrombocytopenia, the diagnosis of vaccine-induced immune thrombotic thrombocytopenia (VITT) was strongly suspected.PFKFB4 Antibody Cancer This condition, first reported in early 2021, is characterized by anti-PF4 antibodies that activate platelets and trigger widespread thrombosis [1, 2].HIF2a Antibody Epigenetics Immediate intervention was critical.PMID:35174478 To rapidly neutralize pathogenic antibodies via Fc receptor blockade, high-dose intravenous immunoglobulin (IVIG) therapy was initiated at 1 g/kg body weight on day 1 and day 2 post-admission [3, 4]. Although the platelet count rose only marginally within the first 24 hours, it improved significantly to 98/nL after 48 hours (Fig. 2).

Simultaneously, due to the high risk of fatal hemorrhage from existing thrombi, standard anticoagulation with heparin was contraindicated. Instead, argatroban—a direct thrombin inhibitor—was started immediately following the first IVIG dose. Its short half-life and suitability for continuous infusion made it ideal for managing severe, life-threatening thrombosis in a bleeding-prone patient [5]. Anticoagulant intensity was monitored through frequent PTT measurements, maintained at 1.5 times baseline (50–60 seconds) (Fig. 2).

During the first night in the neurology unit, after receiving 90 g of IVIG, the patient suffered two consecutive epileptic seizures. A non-contrast head CT revealed a new left temporo-parietal intracranial hemorrhage (Fig. 1c), likely secondary to venous congestion from impaired drainage. The patient subsequently developed moderate aphasia and apraxia, necessitating initiation of antiepileptic drugs.

After the second IVIG dose and normalization of platelet counts, D-dimer levels declined sharply—from 65.7 mg/L at presentation to 12.32 mg/L within 48 hours (Fig. 2). With sustained argatroban infusion maintaining a mean PTT of 42 seconds, clinical improvement followed. By day 16, MRI demonstrated progressive recanalization of the transverse and sigmoid sinuses (Fig. 1b), along with resolution of portal and mesenteric vein thromboses. Lactate levels remained normal, and no further abdominal distress occurred.

Confirmatory testing performed days after recovery confirmed PF4-dependent platelet activation in pre-IVIG blood samples, validating the VITT diagnosis [1]. This case illustrates that early administration of high-dose IVIG combined with argatroban-based anticoagulation—without heparin or platelet transfusions—is pivotal in preventing death in severe VITT. Among 16 published cases (11 in Germany and Austria, 5 in Norway), nine patients died. Only those treated promptly with IVIG and avoiding platelet replacement or heparin survived. These findings reinforce a key principle: immediate immune modulation followed by targeted, non-heparin anticoagulation is essential in halting the progression of this deadly syndrome.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com

The development of advanced biomaterials capable of mimicking the dynamic and heterogeneous nature of the extracellular matrix (ECM) is critical for next-generation cell culture systems. This study presents a modular hydrogel platform based on engineered bacterial fimbriae protein Caf1, which enables precise control over both mechanical and biochemical properties to guide human dermal fibroblast (hDFB) behavior in two-dimensional environments. Caf1, originally isolated from *Yersinia pestis*, forms highly stable, fibrillar polymers through non-covalent interactions between immunoglobulin-like subunits. Its structural robustness, combined with ease of genetic engineering, makes it an ideal candidate for designing synthetic ECM analogs.

In this work, Caf1 was modified by inserting the Arg-Gly-Asp-Ser (RGDS) peptide motif into loop 5 of its structure, enabling integrin-mediated cell adhesion without chemical modification. By combining wild-type Caf1WT and RGDS-modified Caf1RGDS subunits in varying ratios, researchers created copolymers with tunable bioactivity. These were then crosslinked with 8-arm PEG to form transparent hydrogels at concentrations of 2.5% or 5.0% w/v. The resulting gels exhibited a wide range of stiffness, from ~240 Pa to over 3000 Pa, depending on Caf1 concentration. Importantly, the inclusion of RGDS motifs did not alter mechanical properties, allowing independent tuning of biological signals and physical cues.

Rheological characterization revealed that hydrogels derived from thermally refolded Caf1 exhibited faster stress relaxation than those from native polymers. This behavior stems from shorter polymer chains formed during thermal cycling, leading to reduced network entanglement and increased viscoelasticity. The 2.5%-refolded-Caf1RGDS hydrogel displayed rapid stress relaxation within seconds—comparable to soft biological tissues—and was associated with significantly higher metabolic activity and DNA content in hDFBs compared to stiffer counterparts.

Cellular responses were strongly influenced by these material properties. On RGDS-functionalized gels, cells adhered efficiently, spread extensively, and proliferated robustly. The 2.5%-refolded-Caf1RGDS formulation induced the most favorable phenotype: high metabolic activity, extensive cytoskeletal organization, and elevated collagen I deposition. In contrast, stiffer 5%-native-Caf1RGDS gels promoted elongated, aligned morphologies consistent with high mechanical tension, resembling behavior on tissue culture plastic. Live/dead assays confirmed excellent cytocompatibility across all RGDS-containing gels, with minimal cell death observed.

Scanning electron microscopy showed interconnected porous networks in all hydrogels, facilitating nutrient diffusion and waste removal—key features for long-term culture.Filamin 1 Antibody Epigenetics Notably, the presence of Caf1WT subunits in mixed gels did not impair cell adhesion or viability, indicating a neutral rather than inhibitory effect.Cadherin-17 Proteinmedchemexpress This allows for dilution of expensive bioactive subunits with highly expressed wild-type variants, reducing production costs while maintaining biological function.PMID:33932162

These findings demonstrate that Caf1-based hydrogels offer unprecedented design flexibility. Their ability to independently modulate stiffness, stress relaxation, and ligand density enables fine-tuning of cellular functions such as proliferation, morphology, and ECM secretion. As a scalable, animal-free alternative to conventional ECM materials, this system holds strong potential for applications in drug screening, disease modeling, regenerative medicine, and personalized therapies.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com

The adsorption mechanism of Hg(II) on oxygen-containing MXene was systematically investigated through comprehensive characterization and kinetic modeling. The material’s high surface reactivity stems from the deliberate incorporation of oxygen functional groups during mild etching and ultrasonic delamination, resulting in a rich array of Ti–O, O–H, and C–O sites. These functional groups serve as active centers for both electrostatic attraction and chemical bonding with Hg(II) species. XPS analysis revealed significant shifts in binding energy following adsorption: the Ti 2p peaks shifted slightly toward lower values, while the O 1s component corresponding to O–H and CeOeC bonds exhibited a 0.6 eV and 0.3 eV downward shift, respectively. Concurrently, the C 1s peak associated with carboxyl groups (COO⁻) showed a 0.FAHD2A Antibody web 1 eV upward shift, indicating electron donation from the functional groups to mercury ions—consistent with chemisorption.

FTIR spectroscopy further confirmed these interactions. A prominent peak at 3445 cm⁻¹, attributed to O–H stretching vibrations, intensified after adsorption, suggesting increased hydrogen bonding or coordination with Hg(II). The CeO bond vibration at 1024 cm⁻¹ also shifted, reflecting changes in bond strength due to interaction with mercury. Notably, no new peaks appeared in the FTIR spectrum after Hg(NO₃)₂ adsorption, implying that the process occurred primarily via surface complexation rather than precipitation. In contrast, XRD patterns after HgCl₂ adsorption revealed distinct crystalline peaks at 2θ = 21.4°, 28.1°, 32.8°, and 46.2°, corresponding to crystalline HgCl₂, confirming the formation of solid-phase products during adsorption in chloride-rich media.

Zeta potential measurements demonstrated that the MXene surface becomes increasingly negative above pH 2.03, promoting electrostatic attraction of cationic Hg²⁺ and HgOH⁺ species. This explains the observed increase in adsorption capacity with rising pH up to 4–5, beyond which hydroxide precipitation may reduce availability. However, even at pH 2.0, the adsorbent retained over 90% of its maximum capacity, underscoring the resilience of surface functional groups under extreme acidity—a critical advantage for treating industrial effluents.

Kinetic data fitting using the Elovich model yielded a high initial sorption rate (a ≈ 10.5 mg/g·min), supporting rapid surface reaction. Combined with Boyd model results, the data suggest that adsorption is not limited by internal diffusion but is governed by external mass transfer and interfacial reactions. The absence of a linear fit in the intra-particle diffusion model further confirms that multiple mechanisms operate simultaneously.CCNE1 Antibody References

These findings collectively indicate that Hg(II) removal proceeds through a dual mechanism: (1) electrostatic attraction of Hg²⁺/HgOH⁺ to negatively charged oxygen sites, and (2) covalent-like coordination involving Ti–O and O–H groups, particularly effective in forming stable complexes with Hg(OH)₂.PMID:34137279 The presence of Cl⁻ promotes precipitation of HgCl₂ crystals, enhancing physical retention. Thus, the MXene’s performance is not only due to high surface area but also to the synergistic effect of tailored surface chemistry and dynamic speciation response. This mechanistic understanding paves the way for rational design of next-generation MXene-based adsorbents for heavy metal remediation.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com

The emergence and re-emergence of flaviviruses such as Zika virus (ZIKV), dengue virus (DENV), and yellow fever virus (YFV) continue to threaten global health, particularly in endemic regions like Brazil. With no licensed antiviral therapies available for these infections, the search for effective treatments remains a priority. This study evaluates the antiviral potential of trametinib, a clinically approved MEK inhibitor, against Brazilian strains of ZIKV, DENV2, DENV3, and the YFV 17DD vaccine strain in human cell lines. Trametinib was selected due to its established safety profile in oncology patients and its ability to inhibit the MEK/ERK signaling pathway—a host cascade hijacked by multiple viruses during replication.

Cytotoxicity assays were conducted in both BHK-21 and Vero cells using crystal violet staining after 24- and 48-hour exposures. Results revealed that trametinib exhibited minimal toxicity at concentrations up to 20 µM in Vero cells, with a CC50 exceeding 170 µM, indicating a high therapeutic window.59-05-2 Formula In contrast, bosutinib showed significant cytotoxicity even at low doses, limiting its utility. Antiviral efficacy was assessed via plaque assay following infection with ZIKV PE-243 (MOI 0.1), DENV2 PI59, DENV3 MG20, or YFV 17DD. Cells were treated with increasing concentrations of trametinib (5–40 µM) for 24 hours post-infection. Notably, trametinib reduced viral titers by over 1,000-fold for ZIKV and nearly 100-fold for DENV2, DENV3, and YFV at optimal concentrations. These effects were dose-dependent and statistically significant (p < 0.001). Importantly, trametinib also demonstrated activity against the ZIKV African MR766 strain, reducing viral titers by 10-fold, confirming its broad-spectrum potential.HOXD10 Antibody Description No direct virucidal activity was observed when viruses were pre-incubated with trametinib, suggesting that the compound acts intracellularly by disrupting viral replication processes rather than destroying viral particles. The EC50 values for ZIKV, DENV2, DENV3, and YFV were consistently low—ranging from 2.46 to 6.33 µM—while the SI values exceeded 50, highlighting a favorable balance between potency and safety. Compared to other inhibitors tested—including selumetinib, saracatinib, and bosutinib—trametinib displayed superior efficacy and tolerability.PMID:34687746

Mechanistically, this antiviral effect is likely linked to the inhibition of ERK phosphorylation, which plays a crucial role in regulating cellular processes essential for flavivirus propagation, including viral RNA synthesis, protein translation, and assembly. Previous studies have shown that MEK/ERK activation is induced by DENV and YFV infection, and its blockade impairs viral yield in both cell culture and animal models. Trametinib’s ability to disrupt these pathways may explain its pan-antiviral activity. Furthermore, prior reports indicate that trametinib reduces HIV infectivity by interfering with capsid uncoating and inhibits influenza virus spread by blocking nuclear export of viral ribonucleoproteins—mechanisms consistent with disruption of ERK-dependent trafficking.

Given that trametinib is already FDA-approved for BRAF-mutated melanoma, its repurposing for flavivirus treatment could be expedited through clinical trials. Its strong performance across multiple flaviviruses, combined with an excellent safety margin, positions it as a leading candidate for broad-spectrum antiviral therapy. Future research should focus on validating these findings in primary human cells and in vivo models, as well as exploring combination therapies to enhance antiviral efficacy and prevent resistance. This work underscores the value of targeting host factors in antiviral drug development and provides compelling evidence for trametinib’s potential as a frontline therapeutic against emerging and re-emerging flaviviral diseases.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com

Hydrogen-bonded supramolecular elastomers have emerged as a cornerstone in the development of next-generation wearable electronic devices, offering a unique combination of mechanical robustness, electrical functionality, and autonomous self-repair capability. These materials leverage dynamic, reversible hydrogen bonding interactions—particularly those involving multiple hydrogen-bonding units such as ureidopyrimidinone (UPy), acylsemicarbazide (ASC), and thiourea—to form highly tunable, reconfigurable networks that can rapidly recover after mechanical damage. The ability to self-heal without external intervention or additional healing agents makes them ideal candidates for long-term, reliable operation in flexible and stretchable electronics. This article explores the molecular design principles behind these elastomers, their integration into functional devices, and their transformative role in advancing wearable technologies.

The foundation of these materials lies in the strategic placement of hydrogen-bonding motifs within polymer architectures. When incorporated at chain ends, sidechains, mainchains, or branched sites, these units enable controlled phase separation between hard (hydrogen-bonded) and soft (elastomeric) domains. This microphase-separated morphology imparts both high toughness and excellent elasticity. For example, UPy-functionalized polyurethanes exhibit tensile strengths over 40 MPa and elongation at break exceeding 500%, while maintaining full recovery after cutting and healing. The strength arises from the cooperative nature of quadruple hydrogen bonds, which provide association constants up to 10⁷ M⁻¹, creating a dense, reversible network capable of withstanding significant mechanical stress.

One of the most compelling applications is in self-healing electronic skins (e-skins).Fos B Antibody MedChemExpress These devices mimic human skin by combining sensing, actuation, and self-repair functions. By embedding conductive fillers such as silver nanowires or carbon nanotubes into a hydrogen-bonded matrix, researchers have developed e-skins capable of detecting pressure, strain, temperature, and even subtle biological signals like facial movements and vocal cord vibrations. A key breakthrough came with the development of transparent, room-temperature self-healing films based on PPGTD-IDA—a supramolecular elastomer featuring dynamic hydrogen bonding and metal-ligand coordination. After being cut, these films restored electrical conductivity within seconds, enabling real-time operation of LED circuits and sensor arrays even after repeated damage.

Self-healing conductive films also play a critical role in stretchable interconnects and energy-harvesting systems. In one notable case, a conductive network composed of carbon nanotubes was embedded in a self-healing polyurethane matrix. Upon damage, the film recovered its conductivity fully after 12 hours due to the rapid reformation of hydrogen-bonded crosslinks. Similarly, stretchable triboelectric nanogenerators (TENGs) fabricated using hydrogen-bonded polymers demonstrated nearly 100% recovery of output voltage and current after healing, even under extreme deformation.GFAP Antibody manufacturer These TENGs are particularly valuable for powering wearable sensors through body motion, making them ideal for continuous health monitoring.PMID:35130623

Another major application is in soft actuators designed for robotics and biomedical devices. Inspired by natural muscle systems, these actuators utilize hydrogen-bonded supramolecular networks that respond rapidly to stimuli such as near-infrared (NIR) light. For instance, a biomimetic actuator based on UPy-crosslinked polyurethane achieved bending angles exceeding 90° in under 2 seconds and exhibited a remarkable 99.5% actuating performance recovery after damage. The healing process occurred autonomously at room temperature, allowing the device to function seamlessly after puncturing or cutting. Such capabilities open new possibilities for artificial muscles, wearable rehabilitation devices, and adaptive prosthetics.

Beyond electronics, hydrogen-bonded elastomers are being explored in bio-integrated systems. Dopamine-functionalized elastomers show strong adhesion to biological tissues and have been used to fabricate self-healing bio-electrodes for electromyography (EMG) monitoring. After being cut, these electrodes regained signal integrity within hours, preserving high signal-to-noise ratios and enabling continuous physiological tracking. Additionally, self-healing binders based on SHP-PEG (self-healing poly(ethylene glycol)) have been successfully applied in lithium-ion batteries, where they maintain electrode integrity during volume changes associated with charge-discharge cycles, significantly improving cycle life and Coulombic efficiency.

Despite these advances, challenges remain. Healing efficiency often degrades after multiple cycles due to environmental contamination, such as moisture or dust particles interfering with hydrogen bond formation. Furthermore, many systems still require heat or pressure to initiate healing, limiting their use in ambient conditions. Future research must focus on designing truly autonomous, stimulus-free healing systems—possibly through hierarchical molecular architectures or responsive nanostructures that trigger repair upon damage.

In conclusion, hydrogen-bonded supramolecular elastomers represent a transformative class of materials for wearable electronics. Their ability to combine flexibility, durability, and self-repairability enables the creation of intelligent, resilient, and long-lasting devices. As molecular design becomes more sophisticated and healing mechanisms more autonomous, we anticipate widespread adoption in healthcare, robotics, human-machine interfaces, and sustainable energy systems. The future of wearable technology lies not only in smarter electronics but in materials that can heal themselves—just like living tissue—ushering in an era of truly adaptive, self-sustaining devices.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com

The rational design of single atom catalysts (SACs) with tailored electronic and geometric structures is essential for optimizing electrocatalytic performance in carbon dioxide reduction reactions (CO2RR). In this work, we report a highly effective strategy to engineer the atomic-scale environment of copper atoms on MXene supports through selective etching of quaternary MAX phases. The synthesis involves the controlled removal of aluminum from Ti3(Al1−xCux)C2 via molten ZnCl2 treatment at 600 °C, where AlCl3 sublimates selectively, leaving behind isolated Cu atoms anchored onto the Ti3C2Clx surface. This process not only preserves the structural integrity of the MXene but also ensures uniform dispersion of Cu atoms without aggregation.

Advanced characterization techniques confirm the successful formation of single atom Cu sites. Aberration-corrected high-angle annular dark-field scanning transmission electron microscopy (HAADF-STEM) reveals numerous bright dots corresponding to individual Cu atoms distributed across the MXene layers. X-ray absorption near-edge structure (XANES) analysis shows that Cu exhibits an intermediate oxidation state between Cu⁺ and Cu²⁺, indicating charge transfer from Cu to the surrounding oxygen ligands. Extended X-ray absorption fine structure (EXAFS) fitting confirms three-coordinate O–Cu bonding with a bond length of 1.92 Å, with no evidence of Cu–Cu scattering, proving the absence of clustering.

Surface-sensitive techniques such as X-ray photoelectron spectroscopy (XPS) further support these findings. The Cu 2p₃/₂ peak appears at 933.7 eV, consistent with Cu⁺ species stabilized by oxygen coordination. O 1s spectra show contributions from Ti–O and surface hydroxyl groups, confirming the presence of oxygen-rich functionalization on the MXene surface.HLA-F Antibody supplier The Ti 2p and Cl 2p spectra indicate the retention of dominant surface Cl termination, which enhances the stability of the MXene framework under electrochemical conditions.137234-62-9 Formula

Electrocatalytic evaluation demonstrates that SA-Cu-MXene achieves a Faradaic efficiency of 59.1% for methanol production at −1.4 V vs RHE, among the highest reported for SACs in CO2RR.PMID:34319926 The current density reaches 21.3 mA cm⁻² under identical conditions, significantly higher than that of Cu-particles-MXene (9.6 mA cm⁻²) and pristine MXene (3.7 mA cm⁻²). Chronoamperometry tests over a range of potentials reveal a volcano-shaped trend in methanol selectivity, peaking at −1.4 V. Notably, the catalyst maintains >58% Faradaic efficiency after 30 hours of operation, highlighting its robustness.

DFT calculations elucidate the origin of enhanced activity. The Cu–O₃ configuration creates a highly unsaturated electronic structure that facilitates the adsorption and activation of CO2 molecules. The rate-determining step—conversion of HCOOH* to CHO*—is thermodynamically favorable due to a low energy barrier (0.15 eV), attributed to the optimized binding strength of key intermediates. In contrast, nanoparticle Cu surfaces exhibit higher barriers (0.27 eV), leading to less efficient methanol formation. Moreover, the suppression of C–C coupling pathways due to isolated Cu sites favors the selective production of CH3OH over ethylene or ethanol.

This study establishes a clear correlation between atomic-scale structure and catalytic function in SACs. By combining selective etching with precise control over surface chemistry, we demonstrate a powerful approach to engineering single metal atom catalysts with superior activity, selectivity, and stability. The methodology can be extended to other transition metals and layered materials, offering broad potential for next-generation electrocatalysts in renewable energy conversion.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com

The adsorption kinetics of benzo[a]pyrene (BaP) on granular activated carbon (GAC), biochar, and Haplic Chernozem soil were investigated to elucidate the underlying mechanisms governing contaminant retention in environmental systems. Batch kinetic experiments revealed a rapid initial uptake of BaP within the first 60 minutes, during which 77–81% of the total adsorption occurred. This fast phase was attributed to the availability of high-energy surface sites and facile diffusion into macro- and mesopores of the sorbents. Subsequently, the adsorption rate slowed significantly, with only 19–23% of additional BaP being captured over the next hour, indicating the onset of intraparticle diffusion limitations.

This biphasic behavior aligns with established models of porous adsorbent dynamics. The initial stage is dominated by physical interactions such as van der Waals forces and π–π stacking between the aromatic rings of BaP and the graphitic surfaces of GAC and biochar. These interactions are particularly strong due to the high electron density in the carbon matrix, facilitating stable binding of planar polyarene molecules. As the external surface becomes saturated, the slower second phase involves the migration of BaP into narrow micropores (diameter < 2 nm), where access is restricted by steric hindrance and reduced mobility. The presence of polar functional groups on biochar may further influence this process through hydrogen bonding or dipole interactions, although these effects were secondary compared to hydrophobic and π–π interactions. Scanning electron microscopy (SEM) imaging confirmed distinct morphological differences among the materials. GAC displayed a heterogeneous structure with rhombohedral fragments and sieve-like pores, while biochar exhibited elongated cylindrical cavities aligned along the original axis of sunflower husk particles. These features support the observed kinetic patterns: the larger pore volume in biochar facilitated faster initial uptake, whereas the high microporosity of GAC enhanced long-term retention.ATG5 Antibody Technical Information Additionally, laser scanning confocal microscopy revealed that the integral surface area of biochar exceeded that of GAC, despite its lower BET surface area, highlighting the significance of macroporous architecture in enhancing mass transfer.59-05-2 supplier

The influence of solvent composition was also critical.PMID:34772541 Acetonitrile, used to dissolve BaP, affected adsorption efficiency by altering the solvation shell around BaP molecules. At low concentrations, acetonitrile improved BaP availability for adsorption; however, higher levels suppressed sorption due to competitive solvation and increased polarity of the liquid phase. Notably, the distribution coefficient (Kd) for BaP showed a positive correlation with acetonitrile content in GAC and biochar systems, especially at a 0.5:20 solid-to-liquid ratio. In contrast, soil exhibited minimal sensitivity to solvent changes, reflecting its lower affinity and limited porosity.

These results confirm that the interaction mechanisms between BaP and sorbents are governed by both thermodynamic equilibrium and kinetic constraints. While the Freundlich model adequately described the isotherms due to surface heterogeneity, the kinetic data highlight the importance of pore hierarchy and molecular transport dynamics. Ultimately, the superior performance of carbonaceous sorbents stems from their tailored microstructure—combining high surface area, optimal pore size distribution, and favorable surface chemistry—which enables efficient capture and stabilization of persistent organic pollutants like BaP.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com

The expression of programmed death-ligand 1 (PD-L1) in breast cancer is tightly regulated by a complex interplay of genetic, epigenetic, and signaling pathways that influence both tumor-intrinsic and immune-mediated mechanisms. While PD-L1 was initially considered a passive marker of immune evasion, it is now recognized as a dynamically regulated molecule whose levels are shaped by intrinsic oncogenic signals and extrinsic immune stimuli. In breast cancer, particularly in aggressive subtypes such as triple-negative breast cancer (TNBC), aberrant PD-L1 expression contributes to immune suppression and resistance to therapy, making it a compelling therapeutic target.

One of the most well-documented mechanisms driving PD-L1 upregulation is genomic amplification at the 9p24.1 locus, which harbors the PD-L1 (CD274) gene along with PD-L2 and JAK2. This amplicon is enriched in TNBC and HER2-positive tumors and leads to constitutive activation of JAK-STAT signaling, resulting in sustained PD-L1 expression. Notably, PD-L1 protein overexpression does not always correlate with gene amplification, indicating that post-transcriptional and translational regulation also play critical roles. For instance, enhanced mRNA stability via alterations in the 3’-untranslated region (3’-UTR) has been observed in several cancers, including breast cancer, where disruptions in regulatory elements lead to increased PD-L1 translation.

Epigenetic modifications represent another key layer of PD-L1 regulation. Hypomethylation of the PD-L1 promoter has been documented in TNBC cell lines and patient-derived tissues, leading to increased transcriptional activity. Studies have further shown that global DNA hypomethylation in breast cancer patients correlates with elevated PD-L1 expression in peripheral blood and tumor samples. Additionally, histone modifications—including acetylation and trimethylation—modulate chromatin accessibility at the PD-L1 locus. For example, inhibition of histone deacetylases (HDACs) enhances PD-L1 expression, suggesting a potential mechanism for combining HDAC inhibitors with immune checkpoint blockade.

Several oncogenic signaling pathways converge on PD-L1 transcription. The PI3K/AKT/mTOR axis, frequently activated in ER-positive and HER2-positive breast cancers, promotes PD-L1 expression through downstream activation of NF-κB and STAT3. Similarly, EGFR signaling induces PD-L1 via MAPK and STAT3-dependent pathways, especially in TNBC. Inhibiting EGFR or downstream kinases reduces PD-L1 levels, supporting the rationale for combination therapies. Moreover, Wnt/β-catenin signaling—a pathway implicated in cancer stemness—has been linked to PD-L1 upregulation in basal-like TNBC, where activation of canonical Wnt signaling increases PD-L1 expression and enhances tumor cell survival.F2R Antibody Autophagy

Interferons, particularly IFN-γ, are potent inducers of PD-L1 expression.E2F-1 Antibody Technical Information Secreted by activated T cells and NK cells within the tumor microenvironment, IFN-γ signals through JAK1/JAK2 and phosphorylates STAT1/STAT2 dimers, which translocate to the nucleus and bind to interferon-stimulated response elements (ISREs) in the PD-L1 promoter.PMID:33956935 This pathway explains why PD-L1 is often found in high-TIL environments. However, chronic exposure to IFN-γ may lead to feedback inhibition and adaptive resistance, highlighting the need for timely intervention.

Emerging evidence also implicates non-coding RNAs and exosomal trafficking in PD-L1 regulation. MicroRNAs such as miR-513a-3p and miR-200c directly target PD-L1 mRNA, reducing its expression. Conversely, dysregulated miRNAs in breast cancer can derepress PD-L1. Furthermore, tumor-derived exosomes carrying PD-L1 can suppress T-cell function systemically, even in the absence of direct tumor-immune contact. These findings underscore the importance of considering both cellular and paracrine mechanisms in therapeutic design.

Therapeutically, targeting these regulatory pathways offers promising strategies. Combining immune checkpoint inhibitors with agents that modulate PD-L1 expression—such as PARP inhibitors (in BRCA-mutated tumors), HDAC inhibitors, or Wnt antagonists—may overcome resistance and enhance anti-tumor immunity. Preclinical models demonstrate that atezolizumab synergizes with FAK inhibitors or proteasome blockers to induce apoptosis and reduce invasion in PD-L1-positive TNBC cells.

In summary, PD-L1 expression in breast cancer is not static but shaped by multiple intersecting molecular networks. Understanding these mechanisms provides a foundation for developing more effective, personalized immunotherapies. Future research must focus on identifying predictive biomarkers beyond PD-L1, elucidating spatial and temporal dynamics of immune modulation, and designing rational combination regimens to improve outcomes in breast cancer patients.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com